Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Deleterious mutations in ALDH1L2 suggest a novel cause for neuro-ichthyotic syndrome.

Sarret C, Ashkavand Z, Paules E, Dorboz I, Pediaditakis P, Sumner S, Eymard-Pierre E, Francannet C, Krupenko NI, Boespflug-Tanguy O, Krupenko SA.

NPJ Genom Med. 2019 Jul 23;4:17. doi: 10.1038/s41525-019-0092-9. eCollection 2019.

2.

Metabolic constraints of swelling-activated glutamate release in astrocytes and their implication for ischemic tissue damage.

Wilson CS, Bach MD, Ashkavand Z, Norman KR, Martino N, Adam AP, Mongin AA.

J Neurochem. 2019 Oct;151(2):255-272. doi: 10.1111/jnc.14711. Epub 2019 Jun 18.

PMID:
31032919
3.

Presenilin mutations deregulate mitochondrial Ca2+ homeostasis and metabolic activity causing neurodegeneration in Caenorhabditis elegans.

Sarasija S, Laboy JT, Ashkavand Z, Bonner J, Tang Y, Norman KR.

Elife. 2018 Jul 10;7. pii: e33052. doi: 10.7554/eLife.33052.

4.

CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G0/G1 to S-phase.

Khan QA, Pediaditakis P, Malakhau Y, Esmaeilniakooshkghazi A, Ashkavand Z, Sereda V, Krupenko NI, Krupenko SA.

PLoS One. 2018 Jul 6;13(7):e0199699. doi: 10.1371/journal.pone.0199699. eCollection 2018.

5.

Metabolic Reprogramming by Folate Restriction Leads to a Less Aggressive Cancer Phenotype.

Ashkavand Z, O'Flanagan C, Hennig M, Du X, Hursting SD, Krupenko SA.

Mol Cancer Res. 2017 Feb;15(2):189-200. doi: 10.1158/1541-7786.MCR-16-0317.

6.

Silymarin potentiates the anti-inflammatory effects of Celecoxib on chemically induced osteoarthritis in rats.

Ashkavand Z, Malekinejad H, Amniattalab A, Rezaei-Golmisheh A, Vishwanath BS.

Phytomedicine. 2012 Oct 15;19(13):1200-5. doi: 10.1016/j.phymed.2012.07.008. Epub 2012 Aug 25.

PMID:
22925727

Supplemental Content

Loading ...
Support Center